Efficacy And Safety Results Of The Avalglucosidase Alfa Phase 3 Comet Trial In Late-Onset Pompe Disease Patients
MOLECULAR GENETICS AND METABOLISM(2021)
Key words
avalglucosidase alfa,comet trial,disease,patients,late-onset
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined